Sarcoma is a category of cancer in dogs that develops from connective tissues like fat, muscle, nerves, blood vessels, and bone. It accounts for a significant portion of canine cancers and ranges from slow-growing, low-grade skin tumors to aggressive bone cancers that spread quickly. The two broadest categories are soft tissue sarcomas, which develop in muscles, nerves, and fat, and bone sarcomas (osteosarcoma), which arise in the skeleton.
Soft Tissue Sarcoma vs. Osteosarcoma
Though both types share a common cell origin, soft tissue sarcomas and osteosarcomas behave very differently and require different treatment approaches. Understanding which type your dog has is the single most important factor in knowing what to expect.
Soft tissue sarcomas (STSs) grow in the connective tissues under the skin or within the body. The most common subtypes include peripheral nerve sheath tumors, fibrosarcoma, liposarcoma, and perivascular wall tumors. These tumors tend to be locally invasive, meaning they aggressively infiltrate surrounding tissue, but many are slow to spread to distant organs. They can appear almost anywhere on the body.
Osteosarcoma is a bone cancer and the most common primary bone tumor in dogs. It overwhelmingly favors the limbs, with 64% of cases occurring in the front legs and 36% in the hind legs. The upper arm bone (humerus) is the single most common location at about 21% of cases, followed by the thigh bone (femur) at 18.5% and the forearm (radius) at 14%. Unlike many soft tissue sarcomas, osteosarcoma is highly aggressive and spreads to the lungs early. By the time it’s diagnosed, microscopic spread has already occurred in most dogs.
Breeds at Higher Risk
Large and giant breeds carry the highest risk for osteosarcoma. In a study of 744 dogs, Rottweilers made up 17% of cases, followed by golden retrievers (12%), Labrador retrievers (11%), Doberman pinschers (6%), and greyhounds (5%). German shepherds, Saint Bernards, Irish wolfhounds, Great Danes, and Great Pyrenees also appeared frequently. Genomic research has identified specific genetic regions that account for 50 to 80% of osteosarcoma risk in Irish wolfhounds, greyhounds, and Rottweilers.
Breed predispositions also exist for other sarcoma types. Bernese mountain dogs are particularly prone to histiocytic sarcoma, a fast-moving cancer of immune cells. Mastiffs and Rhodesian ridgebacks have been linked to higher sarcoma rates through genome-wide association studies.
What a Sarcoma Looks and Feels Like
Soft tissue sarcomas typically appear as lumps under the skin. They can feel soft or firm and are usually attached to deeper structures rather than sliding freely beneath the skin (the way a benign fatty lump, or lipoma, often does). This attachment is one clue that a lump may be something more concerning, though it’s not definitive. What makes these tumors deceptive is that they often feel well-defined to the touch, as if they have a clear boundary. In reality, they send microscopic fingers of cancer cells in all directions, extending well beyond what you or your vet can feel. The true size of the tumor is almost always larger than it seems.
Osteosarcoma usually shows up as lameness or swelling at a limb joint. Dogs may suddenly start favoring a leg, and the area over the affected bone can become visibly swollen and painful to the touch. In some cases, the weakened bone fractures before the cancer is diagnosed.
How Sarcomas Are Graded
Soft tissue sarcomas are assigned a grade from I to III based on how the cells look under a microscope. This grade is one of the strongest predictors of how the cancer will behave.
- Grade I: Low-grade tumors that grow slowly. Metastasis (spread to other organs) is rare, and even when surgical margins are close, most grade I tumors don’t come back.
- Grade II: Intermediate behavior. These tumors have a moderate chance of local recurrence and a somewhat higher risk of spread.
- Grade III: High-grade tumors with the greatest likelihood of both recurrence and metastasis to the lungs or other organs.
The grade can only be determined from a tissue biopsy, not from a needle sample or by how the tumor looks on the outside.
Diagnosis
If your vet finds a suspicious lump, the first step is usually a fine needle aspirate, where a small needle is inserted into the mass to collect cells. This can sometimes confirm that a tumor is a sarcoma, but sarcomas are notoriously difficult to diagnose this way because their cells don’t shed easily. Many cases require an incisional biopsy, where a small wedge of tissue is removed surgically and sent to a pathologist. The biopsy provides both the diagnosis and the tumor grade.
Staging, the process of checking whether cancer has spread, typically involves chest X-rays (since the lungs are the most common site of metastasis) and sometimes abdominal ultrasound or advanced imaging of the tumor itself. For osteosarcoma, X-rays of the affected bone often show a characteristic pattern of bone destruction that raises suspicion even before biopsy results come back.
Treatment for Soft Tissue Sarcomas
Surgery is the primary treatment. The goal is to remove the tumor with wide margins of normal tissue on all sides, ideally 2 to 3 centimeters in every direction and at least one tissue layer deep. Because these tumors extend far beyond their visible borders, achieving clean margins sometimes requires aggressive surgery. Tumors on the limbs may require amputation if a wide excision isn’t possible.
When surgery doesn’t achieve clean margins, or when the tumor is in a location that limits how much tissue can be removed, radiation therapy is commonly recommended. Radiation can significantly improve local control, reducing the chance the tumor grows back at the same site. A full course of radiation typically costs between $2,500 and $7,000, while major surgical procedures generally start around $500 and increase depending on complexity and location.
Chemotherapy plays a smaller role in most soft tissue sarcomas. It’s generally reserved for high-grade (grade III) tumors where the risk of metastasis is meaningful, or for specific subtypes that are known to be more aggressive.
Treatment for Osteosarcoma
Osteosarcoma treatment is more urgent because the cancer spreads early and aggressively. The standard approach combines amputation of the affected limb with follow-up chemotherapy. Dogs treated with amputation alone have a median survival of about 150 days (roughly 5 months). Adding chemotherapy after surgery extends that to a median of approximately 353 days (nearly 12 months). This difference held true even after excluding dogs that already had visible spread at diagnosis.
Most dogs adapt remarkably well to life on three legs, often returning to normal activity within a few weeks. Limb-sparing surgery, where the cancerous bone is replaced rather than the whole leg being removed, is an option for certain tumor locations but isn’t suitable for every case.
For dogs whose owners choose not to pursue amputation, palliative care focused on pain management can maintain quality of life for a time, though the timeline is shorter.
Newer Approaches: Immunotherapy
Researchers are exploring cancer vaccines for certain sarcoma types, particularly hemangiosarcoma, a highly aggressive cancer of blood vessel cells. In one trial, dogs received a vaccine made from tumor cell proteins alongside standard chemotherapy. The vaccine was safe and triggered immune responses, with most dogs producing antibodies against the cancer cells. While still an emerging area, immunotherapy combined with conventional treatment is showing enough promise that clinical trials continue to expand.
What Affects a Dog’s Outlook
Prognosis varies enormously depending on the type, grade, and location of the sarcoma. A low-grade soft tissue sarcoma removed with wide margins may never come back, and many dogs live out their normal lifespan. A grade III soft tissue sarcoma or an osteosarcoma carries a more guarded prognosis, with the risk of spread being the main concern.
The factors that matter most are tumor grade, whether clean surgical margins were achieved, and whether the cancer has already spread at the time of diagnosis. Your veterinarian or veterinary oncologist will use these specifics to give you the clearest picture of what to expect for your individual dog.